Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

11.35
+0.10000.89%
Post-market: 11.350.00000.00%16:04 EDT
Volume:153.21K
Turnover:1.73M
Market Cap:567.52M
PE:-9.57
High:11.41
Open:11.22
Low:11.17
Close:11.25
Loading ...
Jun 28, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Major Issues Report

8-K - Current report
Mar 04, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report